OncoSec Medical Inc (ONCSQ)

[dangerM]

Hi Chickpea,

I carefully read SITC abstract guidelines* and compared to the guidance for 2H2018**.

I expect some biomarker study, perhaps already from the new research collaboration with Dr. Lo.

However, we did not receive a press statment of complete enrollment yet and the late breaking abstract submission deadline for SITC has already passed. So I wouldn't bet the farm on a SITC presentation of pisces results, at least not the complete ones. The company hasn't promised this either; alone if you add 24 weeks for the primary endpoint https://clinicaltrials.gov/ct2/show/NCT03132675 you will have to wait until end of March. Of course this does not rule out stopping the trial early for efficiency and reaching the primary endpoint before that date, sth. we all hope for.

dM

*

13.09. late breaking abstracts submission -> 24.09. notification (must have previously sent application by 5 p.m. PDT on Aug. 1, 2018 to be eligible for the LBA submission period. ... if not successful, regular abstract by 5 p.m. PDT on Aug. 15, 2018)
01.10. Regular abstract titles
01.11. Late breaking titles

**

- Complete enrollment of 23 patients in Stage 1 of PISCES/KEYNOTE-695 in the third quarter
- Provide topline data update from Stage 1 PISCES/KEYNOTE-695

https://ir.oncosec.com/press-releases/detail/1948/oncosec-provides-outlook-for-second-half-of-2018